Product
Quadrivalent Influenza High-Dose Vaccine
Aliases
Fluzone High-Dose Quadrivalent®
3 clinical trials
1 indication
Indication
Influenza ImmunizationClinical trial
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adults Aged 18 Years and OlderStatus: Completed, Estimated PCD: 2024-04-02
Clinical trial
A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and AboveStatus: Recruiting, Estimated PCD: 2025-05-22
Clinical trial
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adults Aged 18 Years and OlderStatus: Completed, Estimated PCD: 2024-01-19